1. Home
  2. PMM vs NMRA Comparison

PMM vs NMRA Comparison

Compare PMM & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMM
  • NMRA
  • Stock Information
  • Founded
  • PMM 1989
  • NMRA 2019
  • Country
  • PMM United States
  • NMRA United States
  • Employees
  • PMM N/A
  • NMRA N/A
  • Industry
  • PMM Investment Managers
  • NMRA
  • Sector
  • PMM Finance
  • NMRA
  • Exchange
  • PMM Nasdaq
  • NMRA Nasdaq
  • Market Cap
  • PMM 264.8M
  • NMRA 287.6M
  • IPO Year
  • PMM N/A
  • NMRA 2023
  • Fundamental
  • Price
  • PMM $5.97
  • NMRA $0.64
  • Analyst Decision
  • PMM
  • NMRA Buy
  • Analyst Count
  • PMM 0
  • NMRA 8
  • Target Price
  • PMM N/A
  • NMRA $9.29
  • AVG Volume (30 Days)
  • PMM 118.3K
  • NMRA 876.3K
  • Earning Date
  • PMM 01-01-0001
  • NMRA 05-12-2025
  • Dividend Yield
  • PMM 4.68%
  • NMRA N/A
  • EPS Growth
  • PMM N/A
  • NMRA N/A
  • EPS
  • PMM 0.23
  • NMRA N/A
  • Revenue
  • PMM N/A
  • NMRA N/A
  • Revenue This Year
  • PMM N/A
  • NMRA N/A
  • Revenue Next Year
  • PMM N/A
  • NMRA N/A
  • P/E Ratio
  • PMM $26.52
  • NMRA N/A
  • Revenue Growth
  • PMM N/A
  • NMRA N/A
  • 52 Week Low
  • PMM $5.00
  • NMRA $0.62
  • 52 Week High
  • PMM $6.42
  • NMRA $17.19
  • Technical
  • Relative Strength Index (RSI)
  • PMM 50.36
  • NMRA 27.87
  • Support Level
  • PMM $5.70
  • NMRA $0.73
  • Resistance Level
  • PMM $6.00
  • NMRA $0.72
  • Average True Range (ATR)
  • PMM 0.10
  • NMRA 0.06
  • MACD
  • PMM 0.02
  • NMRA 0.02
  • Stochastic Oscillator
  • PMM 52.94
  • NMRA 4.91

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

Share on Social Networks: